Merz Connect
Support for You, Your Office, and Your Patients
The Merz Reimbursement Field Team has been trained to understand coverage and reimbursement for XEOMIN. Specialists are available to assist you and your office with supporting patient access to XEOMIN therapy.
Call and learn how your commercially insured patients may qualify to save up to $5,000 annually*†
For assistance, call 1-855-4MERZTX (1-855-463-7989) to reach a MERZ CONNECT specialist Monday through Friday between 8 AM and 7 PM ET
Information provided by MERZ CONNECT and the Reimbursement Access Managers is intended solely for educational purposes and does not constitute legal advice. Merz disclaims any responsibility for claims and codes submitted by healthcare providers and does not guarantee that coverage and reimbursement will result. It is the healthcare provider's responsibility to determine appropriate codes, charges, and modifiers, and to submit bills for services and products consistent with what was rendered, as well as the patient's insurer requirements.
Pricing
J0588 Is the Specific J-Code For XEOMIN 1 Unit
In our pursuit to bring better outcomes to more patients, Merz Therapeutics takes a responsible approach to price. As you evaluate toxin pricing with the unique needs of your patients in mind, we believe XEOMIN remains a great choice for your patients and practice.
Download J Code FlashcardCoverage & Affordability
Our commercially insured Patient Savings Program covers related eligible administrative services to XEOMIN, not just product costs*†
$0 out of pocket*†
90%
Commercial coverage‡§||88%
Medicaid coverage‡||¶100%
coverage for Medicare‡||**First line†† every time for FDA-approved indications with top 5‡‡ national payers||
Healthcare®7
XEOMIN is 1 of 2 first-line toxins available for HUMANA patients with Commercial and Medicare Advantage.1-3
Patient Support
Access
Enrollment
Meeting the needs of people living with movement disorders & neurological conditions
At Merz Therapeutics, we seek to address the unique needs of people who suffer from movement disorders, neurological conditions, and other health conditions that severely impact patients’ quality of life.
Founded in 1908 by Friedrich Merz
Globally headquartered in Frankfurt, Germany
Privately held for more than 110 years
>3000 employees globally
34 locations worldwide with product availability in over 100 countries